Biased Reviewers?

Regarding the Commentary by Edzard Ernst on peer reviewers and alternative treatements,1 how can this study be called a randomized and controlled study when the reviewers are "conditioned beforehand" with the fact that one of the treatments is "unconventional"? Did the study authors identify the nature of the unconventional treatment? Was it scientifically valid with respect to obesity? Was there a rationale reason for using it? Ernst gives no consideration to these factors. The results r

Written bySaul Green
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Regarding the Commentary by Edzard Ernst on peer reviewers and alternative treatements,1 how can this study be called a randomized and controlled study when the reviewers are "conditioned beforehand" with the fact that one of the treatments is "unconventional"? Did the study authors identify the nature of the unconventional treatment? Was it scientifically valid with respect to obesity? Was there a rationale reason for using it? Ernst gives no consideration to these factors.

The results reported are a self-fulfilling prophecy. He assured that there would be an especially close examination of the paper by peer reviewers by advertising that one of the treatments was "unconventional." This was the straw man set up to provoke rejection and to support a charge of bias.

What is bias? I recently sent a paper critical of an alternative medical treatment to an alternative medical journal. It had well over 50 references in support of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies